These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 36996933)

  • 1. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
    Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
    Softic S; Cohen DE; Kahn CR
    Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the contribution of a high-fructose corn syrup formulation to hepatic glycogen synthesis during ad-libitum feeding in mice.
    DiNunzio G; Belew GD; Torres AN; Silva JG; Silva LP; Barosa C; Tavares L; Jones JG
    Sci Rep; 2020 Jul; 10(1):12852. PubMed ID: 32733017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex-specific manner.
    Bhat SF; Pinney SE; Kennedy KM; McCourt CR; Mundy MA; Surette MG; Sloboda DM; Simmons RA
    J Physiol; 2021 Mar; 599(5):1487-1511. PubMed ID: 33450094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation.
    Mock K; Lateef S; Benedito VA; Tou JC
    J Nutr Biochem; 2017 Jan; 39():32-39. PubMed ID: 27768909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
    Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
    J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
    Rivera JC; Espinoza-Derout J; Hasan KM; Molina-Mancio J; Martínez J; Lao CJ; Lee ML; Lee DL; Wilson J; Sinha-Hikim AP; Friedman TC
    Front Endocrinol (Lausanne); 2024; 15():1282231. PubMed ID: 38756999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.
    Chung M; Ma J; Patel K; Berger S; Lau J; Lichtenstein AH
    Am J Clin Nutr; 2014 Sep; 100(3):833-49. PubMed ID: 25099546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of perinatal exposure to sucrose or high fructose corn syrup (HFCS-55) on adiposity and hepatic lipid composition in rat offspring.
    Toop CR; Muhlhausler BS; O'Dea K; Gentili S
    J Physiol; 2017 Jul; 595(13):4379-4398. PubMed ID: 28447343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review.
    Coronati M; Baratta F; Pastori D; Ferro D; Angelico F; Del Ben M
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
    Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
    Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on Insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced Obesity.
    Valle M; St-Pierre P; Pilon G; Marette A
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease.
    Larner DP; Morgan SA; Gathercole LL; Doig CL; Guest P; Weston C; Hazeldine J; Tomlinson JW; Stewart PM; Lavery GG
    Endocrinology; 2016 Sep; 157(9):3493-504. PubMed ID: 27384305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice.
    Wayal V; Hsieh CC
    Biomed Pharmacother; 2023 Dec; 168():115724. PubMed ID: 37852102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
    Ganz M; Csak T; Szabo G
    World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
    Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS
    J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
    Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
    J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.